Does People’s University offers a BPharm programme in 2025?
-
1 Answer
-
Yes, People's University is offering its BPharm programme for the 2025 academic session. This four-year course is open to eligible students interested in the pharmaceutical field. The university also provides a lateral entry option for DPharm holders. Applicants are encouraged to check the official website for detailed information on curriculum, fees, and admission timelines.
Similar Questions for you
People's University's People's Institute of Management and Research (PIMR) is a top MBA college in India that offers an MBA in Hospital Administration program.
PIMR is known for its academic standards, infrastructure, industry-linkage, and placement record.
Some popular MBA in Hospital Management programs include:
CAT, MAT, XAT, SNAP, NMAT, and ATMA.
Some popular colleges offering MBA in Hospital Management courses include: IIM Calcutta, Chandigarh University, IIM Bodh Gaya, and GIM.
Graduates of the MBA in Hospital Administration programme can work in sectors such as consultancy, diagnostics, hospitals, insurance, i
Fees for the BBA course at People's University typically range from INR 50,000 to INR 80,000 per year.
students also have to take care of books, lab fees and other personal expenses, which can increase the total cost.
Due to the scholarships offered by the university, the cost of BBA can be low for eligible students, making it more accessible and affordable.
The fees for a B.Pharm programme at People's University Bhopal typically range from INR 70,000 to INR 1,00,000 per year. This can include tuition, examination, and other administrative charges. For precise and current fee details, including any additional costs, it's best to consult the official university website or contact the admissions office directly.
Taking an Exam? Selecting a College?
Get authentic answers from experts, students and alumni that you won't find anywhere else
Sign Up on ShikshaOn Shiksha, get access to
- 65k Colleges
- 1.2k Exams
- 687k Reviews
- 1800k Answers
